Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Bobillo · SciRah

Researcher profile · Semantic Scholar

S. Bobillo

Share profile

S. Bobillo — researcher profile on SciRah

h-index: 17
Works: 73
Citations: 1,084

Most-cited papers

Cell free circulating tumor DNA in cerebrospinal fluid detects and monitors central nervous system involvement of B-cell lymphomas
S. Bobillo, M. Crespo, L. Escudero, R. Mayor +16 more
2020Haematologica119 citations Open access
Semantic Scholar
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
S. Bobillo, E. Joffe, D. Sermer, P. Mondello +18 more
2021Blood Cancer Journal66 citations Open access
Semantic Scholar
Prevention and management of secondary central nervous system lymphoma
S. Bobillo, J. Khwaja, A. Ferreri, K. Cwynarski
2022Haematologica65 citations Open access
Semantic Scholar
Prognostic impact of total metabolic tumor volume in large B-cell lymphoma patients receiving CAR T-cell therapy
G. Iacoboni, M. Simó, G. Villacampa, E. Catalá +10 more
2021Annals of Hematology62 citations
Semantic Scholar
Rituximab maintenance after first-line therapy with rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) for chronic lymphocytic leukemia.
P. Abrisqueta, N. Villamor, M. Terol, E. González-Barca +18 more
2013Blood61 citations Open access
Semantic Scholar
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
P. Ghione, M. Palomba, Anik R Patel, S. Bobillo +13 more
2022Blood60 citations Open access
Semantic Scholar
Clinical Characteristics and Outcomes of Extranodal Stage I Diffuse Large B Cell Lymphoma in The Rituximab-Era.
S. Bobillo, E. Joffe, J. Lavery, D. Sermer +19 more
2020Blood55 citations Open access
Semantic Scholar
Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
P. Ghione, M. Palomba, H. Ghesquières, S. Bobillo +13 more
2022Haematologica50 citations Open access
Semantic Scholar
ALK-negative anaplastic large cell lymphoma: features and outcomes of 235 patients from the International T-Cell Project.
A. Shustov, M. Cabrera, M. Civallero, M. Bellei +17 more
2021Blood Advances47 citations Open access
Semantic Scholar
Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes
J. Montoro, L. Gallur, B. Merchan, A. Molero +10 more
2018Annals of Hematology46 citations
Semantic Scholar
Mosunetuzumab in Combination with Lenalidomide Has a Manageable Safety Profile and Encouraging Activity in Patients with Relapsed/Refractory Follicular Lymphoma: Initial Results from a Phase Ib Study
F. Morschhauser, M. Bishton, T. Eyre, E. Bachy +13 more
2021Blood40 citations Open access
Semantic Scholar
Repolarization of tumor infiltrating macrophages and increased survival in mouse primary CNS lymphomas after XPO1 and BTK inhibition
I. Jiménez, J. Caràbia, S. Bobillo, C. Palacio +14 more
2020Journal of Neuro-Oncology33 citations Open access
Semantic Scholar
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study
A. García-Sancho, M. Bellei, M. López-Parra, G. Gritti +27 more
2022Haematologica31 citations Open access
Semantic Scholar
Promising activity of selinexor in the treatment of a patient with refractory diffuse large B-cell lymphoma and central nervous system involvement
S. Bobillo, P. Abrisqueta, C. Carpio, P. Raheja +3 more
2017Haematologica29 citations Open access
Semantic Scholar
Posttransplant cyclophosphamide after allogeneic hematopoietic cell transplantation mitigates the immune activation induced by previous nivolumab therapy
J. C. Nieto, E. Roldán, I. Jiménez, L. Fox +14 more
2020Leukemia25 citations
Semantic Scholar
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program
V. García-Gutiérrez, A. Martínez-Trillos, J. L. Lorenzo, G. Bautista +24 more
2015American journal of hematology/oncology20 citations Open access
Semantic Scholar
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure who reach complete response after rescue treatment
A. Jiménez-Ubieto, C. Grande, D. Caballero, L. Yáñez +23 more
2018Hematological Oncology18 citations
Semantic Scholar
Preliminary Findings of a Phase Ib/II Trial Indicate Manageable Safety and Promising Efficacy for Mosunetuzumab in Combination with Lenalidomide (M+Len) in Previously Untreated (1L) Follicular Lymphoma (FL)
F. Morschhauser, K. Patel, S. Bobillo, R. Córdoba +16 more
2023Blood17 citations Open access
Semantic Scholar
CNS prophylaxis in aggressive B-cell lymphoma.
M. Wilson, S. Bobillo, K. Cwynarski
2022Hematology. American Society of Hematology. Education Program17 citations Open access
Semantic Scholar
High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients
K. Lewis, L. Jakobsen, D. Villa, S. Bobillo +46 more
2021Blood17 citations Open access
Semantic Scholar
PET‐based radiomics signature can predict durable responses to CAR T‐cell therapy in patients with large B‐cell lymphoma
M. Ligero, M. Simó, C. Carpio, G. Iacoboni +11 more
2023eJHaem15 citations Open access
Semantic Scholar
Mortality in acquired thrombotic thrombocytopenic purpura in the pre-caplacizumab era
J. del Río-Garma, S. Bobillo, J. de la Rubia, C. Pascual +18 more
2021Annals of Hematology14 citations
Semantic Scholar
A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma
M. Palomba, P. Ghione, Anik R Patel, M. Nahas +11 more
2023Expert Review of Anticancer Therapy13 citations Open access
Semantic Scholar
Early progression in follicular lymphoma in the absence of histological transformation or high‐risk Follicular Lymphoma International Prognostic Index still has a favourable outcome
A. Muntañola, P. Mozas, S. Mercadal, M. Huguet +16 more
2022British Journal of Haematology13 citations
Semantic Scholar
Real‐world data with the use of caplacizumab in the treatment of acquired thrombotic thrombocytopenic purpura: A single‐center with homogeneous treatment experience
M. Jiménez, S. Bobillo, V. Pons, C. Sanchez +7 more
2022Transfusion12 citations
Semantic Scholar
A Comparison of Clinical Outcomes from Updated Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R FL)
M. Palomba, P. Ghione, Anik R Patel, K. Deighton +14 more
2021Blood11 citations Open access
Semantic Scholar
Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma.
D. Sermer, S. Bobillo, A. Dogan, Yan-Ming Zhang +21 more
2020Blood Advances11 citations Open access
Semantic Scholar
Progression‐free survival at 2 years post‐autologous transplant: a surrogate end point for overall survival in follicular lymphoma
A. Jiménez-Ubieto, C. Grande, D. Caballero, L. Yáñez +23 more
2017Cancer Medicine11 citations Open access
Semantic Scholar
CNS prophylaxis for diffuse large B-cell lymphoma.
T. Eyre, K. Savage, Che-Ah Y. Chan, T. El-Galaly +9 more
2022The Lancet Oncology10 citations Open access
Semantic Scholar
Use of checkpoint inhibitors in patients with lymphoid malignancies receiving allogeneic cell transplantation: a review
S. Bobillo, J. C. Nieto, P. Barba
2021Bone Marrow Transplantation9 citations
Semantic Scholar
Immunological and genetic kinetics from diagnosis to clinical progression in chronic lymphocytic leukemia
I. Jiménez, B. Tazón-Vega, P. Abrisqueta, J. C. Nieto +14 more
2021Biomarker Research9 citations Open access
Semantic Scholar
Phase 3 trial of odronextamab plus lenalidomide versus rituximab plus lenalidomide in relapsed/refractory (R/R) follicular lymphoma (FL) and marginal zone lymphoma (MZL; OLYMPIA-5).
Umberto Vitolo, M. Merli, L. Norasetthada, Tim Wassenaar +11 more
2024Journal of Clinical Oncology8 citations Open access
Semantic Scholar
XPO1 Inhibition By Selinexor Synergizes with BCR Inhibition, Blocks Tumor Growth and Prolongs Survival in a Bioluminescent Animal Model of Primary Central Nervous System Lymphoma
M. Crespo, J. Caràbia, I. Jiménez, S. Bobillo +7 more
20166 citations
Semantic Scholar
Study of Causes of Death in Patients with Myelodysplastic Syndrome: A Single Institution Experience
J. Montoro, T. Vallespí, E. Sancho, O. Salamero +8 more
20116 citations
Semantic Scholar
A 3-Year Follow-up Comparison of Clinical Outcomes from Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma (R/R FL)
P. Ghione, M. Palomba, M. Ray, E. Limbrick-Oldfield +11 more
2022Blood5 citations Open access
Semantic Scholar
Alternative anti-CD20 antibody versus desensitization for lymphoma patients with drug hypersensitivity reactions requiring discontinuation of rituximab, obinutuzumab, or ofatumumab.
P. Ghione, E. Joffe, Nadia E. K. De Paola, T. Mainardi +16 more
20205 citations
Semantic Scholar
Acute Renal Failure Due To Membranoproliferative Glomerulonephritis and Kidney Tumoral Infiltration in a Patient with Mantle Cell Lymphoma
J. Montoro, E. Jatem, P. Abrisqueta, Nerea Castillo +4 more
20155 citations Open access
Semantic Scholar
A Comparison of 3-Year Follow-up of ZUMA-5 (Axicabtagene Ciloleucel) With SCHOLAR-5 in Relapsed/Refractory Follicular Lymphoma.
P. Ghione, M. Palomba, Mark Ray, E. Limbrick-Oldfield +11 more
2024Clinical Lymphoma, Myeloma & Leukemia4 citations
Semantic Scholar
A gene expression assay based on chronic lymphocytic leukemia activation in the microenvironment to predict progression
P. Abrisqueta, Daniel Medina, G. Villacampa, Jun-Yan Lu +11 more
2022Blood Advances4 citations Open access
Semantic Scholar
OUTCOMES IN LATER‐LINES OF THERAPY FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: RESULTS FROM THE INTERNATIONAL SCHOLAR‐5 STUDY
P. Ghione, H. Ghesquières, S. Bobillo, A. R. Patel +13 more
2021Hematological Oncology4 citations Open access
Semantic Scholar
Autologous stem cell transplantation may be curative for patients with follicular lymphoma with early therapy failure without the need for immunotherapy.
A. Jiménez-Ubieto, C. Grande, D. Caballero, L. Yáñez +24 more
2019Hematology/Oncology and Stem Cell Therapy4 citations Open access
Semantic Scholar
Bosutinib Apears to be Safe, with Low Cross Intolerance, in Patients Treated in 4th Line. Results of the Spanish Compassionate Use Program
V. García-Gutiérrez, B. Maestro, A. Martinez-Trillo, J. L. Lorenzo +24 more
20144 citations
Semantic Scholar
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis
M. Wilson, K. Lewis, A. Kirkwood, K. Cwynarski +35 more
2026Journal of Clinical Oncology3 citations Open access
Semantic Scholar
Controversies in central nervous system prophylaxis of high-risk diffuse large B-cell lymphoma
S. Bobillo, M. Wilson, K. Cwynarski
2023Current Opinion in Oncology3 citations
Semantic Scholar
An Updated Comparison of Clinical Outcomes from 4-Year Follow-up of Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed/Refractory Follicular Lymphoma
J. Gribben, P. Ghione, M. Palomba, Mark Ray +11 more
2023Blood3 citations Open access
Semantic Scholar
Ocular involvement in patients with primary central‐nervous‐system lymphoma: Analysis of a multicentre study in Spain
S. Mercadal, M. Alañá, M. Barceló, G. Bruixola +16 more
2022British Journal of Haematology3 citations
Semantic Scholar
Central Nervous System Prophylaxis with High-Dose Intravenous Methotrexate or Intrathecal Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma and High-Risk of CNS Relapse Treated in the Rituximab Era
S. Bobillo, E. Joffe, V. Seshan, A. Noy +16 more
2019Blood3 citations Open access
Semantic Scholar
Central nervous system lymphomas—Assessment and treatment and prevention of central nervous system relapse
P. Ghione, K. Lewis, S. Bobillo, L. Nayak +8 more
2023Hematological Oncology2 citations
Semantic Scholar
Early Relapse after First Line Has a Significant Impact on Overall Survival in Patients with Mantle Cell Lymphoma (MCL)
A. Cabirta, P. Abrisqueta, C. Sánchez-Ruiz, S. Bobillo +9 more
2021Blood2 citations Open access
Semantic Scholar
Real-World Data with the Use of Caplacizumab in the Treatment of Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
M. Jimenez, S. Bobillo, A. Pérez, Pamela Arenas +7 more
20202 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Bosch×15
Invite
F. Bosch — researcher profile on SciRah
P. Ghione×14
Invite
P. Ghione — researcher profile on SciRah
M. Palomba×13
Invite
M. Palomba — researcher profile on SciRah
P. Abrisqueta×11
Invite
P. Abrisqueta — researcher profile on SciRah

×7

Invite

M. Crespo — researcher profile on SciRah

K. Cwynarski×7

Invite

K. Cwynarski — researcher profile on SciRah

Anik R Patel×7

Invite

Anik R Patel — researcher profile on SciRah

H. Ghesquières×7

Invite

H. Ghesquières — researcher profile on SciRah

E. Limbrick-Oldfield×7

Invite

E. Limbrick-Oldfield — researcher profile on SciRah

Invite

C. Carpio — researcher profile on SciRah

Invite

J. Caràbia — researcher profile on SciRah

J. Castellví×6

Invite

J. Castellví — researcher profile on SciRah